1. Which of the following best describes resistance to β-lactams in P. aeruginosa?

2. Which of the following is correct regarding the RESTORE-IMI 2 trial?

3. JL is a 65-year-old woman who has been empirically treated for sepsis with piperacillin/tazobactam for the past five days. Today she develops a high fever and increased purulent secretions. Respiratory cultures identify P. aeruginosa and susceptibilities are currently pending. Which agent is the best choice to switch JL to?

« Return to Activity